Back

MoonLake Immunotherapeutics Stock Predictions

BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty

Click here now to prepare yourself for what's around the corner

Sell

MLTX
MoonLake Immunotherapeutics

Last Price:

42.50

Seasonality Move:

66.96%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

MoonLake Immunotherapeutics Stock Forecast

Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 118.5% based on the past 3 years of stock performance.
MoonLake Immunotherapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is MoonLake Immunotherapeutics Stock Undervalued?
The current MoonLake Immunotherapeutics [MLTX] share price is $42.25. The Score for MLTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
MLTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will MoonLake Immunotherapeutics Stock Go Up Next Year?

Over the next 52 weeks, MoonLake Immunotherapeutics has on average historically risen by 118.5% based on the past 3 years of stock performance.

MoonLake Immunotherapeutics Stock Rating

Sell

MoonLake Immunotherapeutics (MLTX) is a Sell

Is MoonLake Immunotherapeutics overpriced?

MoonLake Immunotherapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

MoonLake Immunotherapeutics Stock Price History

Is MLTX stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MLTX is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

Switzerland

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

moonlaketx.com

52-Week Data

52-Week High:

64.98

52-Week Low:

20.29

Prediction Charts

Market Cap:

2.66B

Price in USD:

42.25

Volume:

264.83K

Beta:

1.21

Technical Analysis

SMA50:

48.47

SMA100:

52.92

SMA200:

52.90

52-Wk Change:

106.2%

Stock Predictions

Is MoonLake Immunotherapeutics stock public?
Yes, MoonLake Immunotherapeutics is a publicly traded company.
What is the MoonLake Immunotherapeutics stock quote today?
The MoonLake Immunotherapeutics stock price is 42.25 USD today.
How to buy MoonLake Immunotherapeutics stock online?
You can buy MoonLake Immunotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-8	47.45	46.24	47.72	46.04
Apr-9	46.41	46.77	47.11	45.63
Apr-10	45.96	46.17	47.09	45.89
Apr-11	46.47	45.64	47.17	44.84
Apr-12	45.35	43.81	45.98	43.35
Apr-15	43.79	43.61	44.17	42.64
Apr-16	43.14	43.50	43.87	43.14
Apr-17	43.71	43.53	43.88	43.45
Apr-18	43.59	42.28	43.70	42.16
Apr-19	42.27	42.15	42.80	40.68
Apr-22	42.41	41.02	42.51	40.72
Apr-23	41.48	43.25	43.26	41.45
Apr-24	43.60	42.43	43.60	41.80
Apr-25	41.68	42.25	42.66	41.20

MoonLake Immunotherapeutics Earnings

MoonLake Immunotherapeutics Earnings Report: Per Share MoonLake Immunotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

MoonLake Immunotherapeutics Forecast Revenue Growth

MoonLake Immunotherapeutics Stock Analysis: Historical quarterly revenues per share for MoonLake Immunotherapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.37 per share, a decrease this year of $0.29 per share, and a decrease next year of $0.59 per share.

* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.